Search results
Showing 691 to 705 of 9082 results
All NICE products on chronic liver disease. Includes any guidance, advice and quality standards.
All NICE products on neuroendocrine tumours. Includes any guidance.
All NICE products on acne. Includes any guidance.
This quality standard covers preventing bacterial infection in newborn babies, treating pregnant women and pregnant people whose babies are at risk of infection, and treating newborn babies with suspected or confirmed bacterial infection. It includes when to give antibiotics to prevent and treat neonatal bacterial infection and describes high-quality care in priority areas for improvement. This includes early-onset (within 72 hours of birth) and late-onset (between 72 hours and 28 days following birth) neonatal infection.
View quality statements for QS75Show all sections
Sections for QS75
- Quality statements
- Quality statement 1: Intrapartum antibiotics
- Quality statement 2: Assessment for early-onset neonatal infection
- Quality statement 3: Prompt antibiotic treatment for neonatal infection
- Quality statement 4: Reassessing antibiotic treatment for neonatal infection
- Quality statement 5: Information and support for parents and carers
- Update information
- About this quality standard
This quality standard covers assessing and managing oesophago-gastric cancer in adults. It describes high-quality care in priority areas for improvement.
All NICE products on vaginal conditions. Includes any guidance.
Dexamethasone and hydrocortisone are both corticosteroids; they have a role in treating COVID-19 in certain people.
All NICE products on inflammatory bowel disease. Includes any guidance, advice and quality standards.
This webpage covers NICE guidelines on breast cancer. The table below presents the guidelines alphabetically with links to the surveillance report...
This quality standard covers the diagnosis and initial management of ectopic pregnancy and miscarriage in women, trans men and non-binary people in their first trimester (up to 13 completed weeks of pregnancy). It includes assessment and diagnosis for people with suspected early pregnancy loss. It describes high-quality care in priority areas for improvement.
View quality statements for QS69Show all sections
Sections for QS69
- Quality statements
- Quality statement 1: Timely referral to early pregnancy assessment services
- Quality statement 2: Ultrasound to identify miscarriage or tubal ectopic pregnancy
- Quality statement 3: Confirming a diagnosis of miscarriage
- Quality statement 4: Anti-D immunoglobulin prophylaxis (up to and including 11+6 weeks of pregnancy)
- Update information
- About this quality standard
All NICE products on infectious disease prevention and control. Includes any guidance, advice and quality standards.
All NICE products on artificial intelligence. Includes any guidance and advice.
All NICE products on complications of cancer. Includes any guidance, advice and quality standards.
All NICE products on eating disorders. Includes any guidance and quality standards.
This webpage covers all NICE's guidelines on cardiometabolic disease prevention and treatment The table presents the guidelines alphabetically within...